Schoenberg Markinsider trades
In SEC Form 4 filings, Schoenberg Mark is listed as Chief Medical Officer of UroGen Pharma Ltd. (URGN). In the last 90 days, Schoenberg Mark sold $2.89M of UroGen Pharma Ltd. (URGN) on the open market and bought none.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| URGNUroGen Pharma Ltd. | Chief Medical Officer | 4 | Sep 9 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-08-24
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| URGNUroGen Pharma Ltd. | Sep 8 | Sep 9 | S | 871 | $42.92 | Sale −$37,383 | 59,882 | No | Form 4 |
| URGNUroGen Pharma Ltd. | Sep 7 | Sep 9 | M | 1,667 | not reported | not reported | 60,753 | No | Form 4 |
| URGNUroGen Pharma Ltd. | Sep 7 | Sep 9 | M · derivative | 1,667 | $0.00 | $0 | not reported | No | Form 4 |
| URGNUroGen Pharma Ltd. | Aug 20 | Aug 24 | S | 60,677 | $47.05 | Sale −$2,854,853 | 59,086 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.